Daniel H. White

All filings by Daniel H. White on record concern Clearside Biomedical, Inc. Over a trading history stretching from 7 June 2016 to 4 June 2018, the count stands at 30 filings.

In open-market terms, that means 1 purchase worth €85k on one side and 25 sales worth €394k on the other. The net balance comes to €309k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants. In 2018 alone, the filings show 1 purchase and no sales.

Most recently, on 4 June 2018, the filings show an open-market purchase worth €85k in Clearside Biomedical, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.